Both in Pharmaceuticals
Spyre Therapeutics vs Madrigal Pharmaceuticals
Over the past year SYRE returned +294.8% and MDGL returned +2.7%; their daily moves had a correlation of 0.18.
SYRE +294.8% MDGL +2.7%Growth of $1, one year, split-adjusted
| Metric | SYRE | MDGL |
|---|---|---|
| Price | $96.56 | $430.36 |
| Market cap | $9.02B | $9.94B |
| Today | −2.43% | −0.31% |
| 1 month | +7.4% | −13.9% |
| 6 months | +39.1% | −16.2% |
| Year to date | +194.7% | −26.1% |
| 1 year | +305.2% | +2.1% |
| Revenue growth (YoY) | — | +71.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −15.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.7× |
| Net cash | $1.15B | $498.0M |
| Dividend yield | — | — |
| Volatility (60d) | 58.7% | 31.0% |
| Short % of float | 15.6% | 14.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).